Naringin demonstrated its cardioprotective nature by reducing the content of proinflammatory cytokines and the expression of transcriptional factor NF-κB, actively involved in developing T2D-induced cardiomyopathy (Lorenzo et al., 2011). This evidence concerns the gene NFKB1 and cardiomyopathy.